German drugmaker Merck KGaA (MRK: DE) announced today that Gerhard Schmitz will join the pharmaceutical, chemical and life science company as the new Head of Global Accounting from November 1. The 50-year-old joins Merck from Lanxess, where he was Head of Accounting. Prior to this he was an Audit Partner at PricewaterhouseCoopers in Germany.
Matthias Zachert, chief financial officer of Merck, said: “We’re pleased that with Gerhard Schmitz we’ve won an experienced manager who has been instrumental to establishing the group-wide accounting function of a global corporation over the past nine years.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze